SAN DIEGO, Dec. 11, 2017 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain purchasers of NYSE:DPLO shares against Diplomat Pharmacy over alleged Violations of Securities Laws.
Investors who purchased shares of Diplomat Pharmacy Inc DPLO in September 2014 or earlier and continue to hold any of those NYSE: DPLO shares should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On November 10, 2016, a lawsuit was filed against Diplomat Pharmacy Inc over alleged securities laws violations. The plaintiff alleged that the defendants made false and/or misleading statements and/or failed to disclose that Diplomat Pharmacy Inc lacked adequate internal controls over its financial reporting, that as a result Diplomat Pharmacy Inc could not adequately calculate DIR fees, that the Company's hepatitis C segment was not performing as previously disclosed to investors, that and therefore, Diplomat Pharmacy Inc had overstated its full-year 2016 guidance, and that that, as a result of the foregoing, defendants' statements about Diplomat Pharmacy Inc's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
On April 11, 2017, an amended complaint was filed and on May 24, 2017 the defendants filed the motion to dismiss the case. A hearing on the motion to dismiss was scheduled for November 30, 2017, however the court has not ruled on the motion yet.
Those who purchased Diplomat Pharmacy Inc DPLO shares should contact the Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
